CIK 0001816590 · Non-accelerated filer<br>Smaller reporting company
COMPASS Pathways plc
Sign in to watch- Ticker
- CMPS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 1-716-676-6461
- Business address
- 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESIRE, United Kingdom, WA14 2DT
- Former names
- Compass Rx Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-01 | Nath Kabir Chief Executive Officer | Shares withheld for taxes | −6,366 | $4.34 | $28K | 221,302 |
| 2025-07-29 | Gover Justin D. Director | Grant or award · Share Option (Right to Buy) | +52,000 | 52,000 | ||
| 2025-06-12 | SANTINI GINO Director | Grant or award · Share Option (Right to Buy) | +39,000 | 39,000 | ||
| 2025-06-12 | Riley Wayne Joseph Director | Grant or award · Share Option (Right to Buy) | +26,000 | 26,000 | ||
| 2025-06-12 | Norton David Y Director | Grant or award · Share Option (Right to Buy) | +26,000 | 26,000 | ||
| 2025-06-12 | McQuade Robert Director | Grant or award · Share Option (Right to Buy) | +26,000 | 26,000 | ||
| 2025-06-12 | McGoldrick Linda Director | Grant or award · Share Option (Right to Buy) | +26,000 | 26,000 | ||
| 2025-06-12 | Lonngren Thomas Director | Grant or award · Share Option (Right to Buy) | +26,000 | 26,000 | ||
| 2025-06-12 | Karydas Daphne Director | Grant or award · Share Option (Right to Buy) | +26,000 | 26,000 | ||
| 2025-06-12 | Jenkins Annalisa Director | Grant or award · Share Option (Right to Buy) | +26,000 | 26,000 | ||
| 2025-03-11 | Goodwin Guy Chief Medical Officer | Grant or award · Share Option (Right to Buy) | +32,000 | 32,000 | ||
| 2025-03-11 | Goodwin Guy Chief Medical Officer | Grant or award · Share Option (Right to Buy) | +63,000 | 63,000 | ||
| 2025-03-11 | Loxam Teri Chief Financial Officer | Grant or award | +25,000 | 83,250 | ||
| 2025-03-11 | Loxam Teri Chief Financial Officer | Grant or award · Share Option (Right to Buy) | +76,000 | 76,000 | ||
| 2025-03-11 | Nath Kabir Chief Executive Officer | Grant or award | +92,000 | 227,668 | ||
| 2025-03-11 | Nath Kabir Chief Executive Officer | Grant or award · Share Option (Right to Buy) | +275,000 | 275,000 | ||
| 2025-03-03 | Loxam Teri Chief Financial Officer | Shares withheld for taxes | −4,468 | $3.67 | $16K | 58,250 |
| 2025-02-03 | Nath Kabir Chief Executive Officer | Shares withheld for taxes | −15,516 | $4.31 | $67K | 135,668 |
| 2024-10-24 | Malievskaia Ekaterina 10% owner | Sale | −776,565 | 3,152,848 | ||
| 2024-10-24 | Malievskaia Ekaterina 10% owner | Sale | −776,565 | 3,155,122 |
Page 2 of 12 · 230 trades